| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |